CLOs on the Move

CooperCompanies

www.coopercos.com

 
The Cooper Companies, Inc. ("Cooper") is a global medical device company publicly traded on the NYSE Euronext (NYSE:COO). Cooper is dedicated to being A Quality of Life Company™ with a focus on delivering shareholder value. Cooper operates through two business units, CooperVision and CooperSurgical. CooperVision brings a refreshing perspective on vision care with a commitment to crafting a wide range of high-quality products for contact lens wearers and providing focused practitioner support. CooperSurgical focuses on supplying women`s health clinicians with market leading products and treatment options to improve the delivery of healthcare to women. Headquartered in Pleasanton, CA, Cooper has ...
  • Number of Employees: 1K-5K
  • Annual Revenue: > $1 Billion
  • www.coopercos.com
  • 6101 Bollinger Canyon Road Suite 500
    San Ramon, CA USA 94583
  • Phone: 925.460.3600

Executives

Name Title Contact Details
Nicholas Khadder
General Counsel and Corporate Secretary Profile

Similar Companies

CAS Medical Systems

CAS Medical Systems is a Branford, CT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Chesapeake

Chesapeake is a Brooklyn, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Blue Medical Supply

Blue Medical Supply is a Jacksonville, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Biosystems of New England

Biosystems of New England is a Waltham, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Sight Sciences

Founded in 2011, Sight Sciences develops and commercializes intelligently designed and engineered products that target the underlying causes of the world`s most prevalent eye diseases. The company`s surgical glaucoma product portfolio features the OMNI Surgical System, a dually indicated MIGS device that facilitates the performance of both ab interno trabeculotomy and transluminal viscoelastic delivery. Using proprietary multi-modal functionality, OMNI allows surgeons to target all three sources of resistance in the conventional outflow pathway (trabecular meshwork, Schlemm`s canal and collector channels) with a single device and single corneal incision. The company`s non-surgical dry eye product portfolio consists of the TearCare for ophthalmologists and optometrists. TearCare is a software-controlled, wearable, therapeutic eyelid technology designed to melt and clear obstructions of the meibomian glands within the eyelids. Leveraging the full functionality of the blinking eye, proprietary SmartLid™ technology is designed to conform to all eyelid anatomies and achieve therapeutic meibum melting temperatures at the tarsal conjunctiva thereby clearing meibomian gland obstructions while sparing the cornea. Improved meibum production results in a higher quality lipid layer and higher quality tears.